The Technical Analyst
Arcelor Mittal NY [MT]
Exchange: NYSE Sector: Basic Materials Industry: Steel
Arcelor Mittal NY Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.09% $25.38
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 20 793 mill |
| EPS: | 0.970 |
| P/E: | 26.16 |
| Earnings Date: | Jul 25, 2024 |
| SharesOutstanding: | 819.27 mill |
| Avg Daily Volume: | 1.636 mill |
| RATING 2024-05-08 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Buy | |
| P/E: | Buy | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.48x |
| Company: PE 26.16 | sector: PE 54.44 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 6.04x |
| Company: PE 26.16 | industry: PE 4.33 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$55.24 (117.65%) $29.86 |
| Date: 2024-05-09 |
| Expected Trading Range (DAY) |
|---|
|
$ 24.77 - 25.99 ( +/- 2.39%) |
| ATR Model: 14 days |
Forecast:
16:00 - $25.38
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $25.38
Forecast 2: 16:00 - $25.38
Forecast 3: 16:00 - $25.38
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $25.38 (-1.09% ) |
| Volume | 0.970 mill |
| Avg. Vol. | 1.636 mill |
| % of Avg. Vol | 59.29 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MT
ArcelorMittal S.A., together with its subsidiaries, operates as integrated steel and mining companies in Europe, North and South America, Asia, and Africa. Its principal steel products include semi-finished flat products, including slabs; finished flat products comprising plates, hot- and cold-rolled coils and sheets, hot-dipped and electro-galvanized coils and sheets, tinplate, and color coated coils and sheets; semi-finished long products, which includes blooms and billets; finished long products, including bars, wire-rods, structural sections, rails, sheet piles, and wire-products; and seamless and welded pipes and tubes. The company's principal mining products comprise iron ore lumps, fines, concentrates, pellets, and sinter feeds; and coking and thermal coal, and pulverized coal injections. It sells its products to various customers in the automotive, appliance, engineering, construction, energy, and machinery industries through a centralized marketing organization, as well as distributors. The company has iron ore mining activities in Brazil, Bosnia, Canada, Kazakhstan, Liberia, Mexico, South Africa, and Ukraine; and coal mining activities in Kazakhstan. ArcelorMittal S.A. was founded in 1976 and is headquartered in Luxembourg City, Luxembourg.
Latest Press Releases
2024-05-02 01:00:00 - Press Release
Arcelormittal S.a.: Arcelormittal Reports First Quarter 2024 Results
Luxembourg, may 2 , 20 24 - arcelormittal (referred to as “arcelormittal” or the “company” or the "group") (mt (new york, amsterdam, paris, luxembourg), mts (madrid)), the world's leading integrated steel and mining company, today announced results1 for the three-month period ended march 31, 2024.
2024-04-30 12:15:00 - Press Release
Arcelormittal Announces Results Of Its General Meeting
30 april 2024, 18:15 cet the annual general meeting (‘general meeting') of shareholders of arcelormittal held today in luxembourg approved all resolutions by a strong majority. 78.47% of the voting rights were represented at the general meeting.
2024-04-25 08:27:00 - Press Release
Arcelormittal S.a.: Arcelormittal Announces The Publication Of Its First Quarter 2024 Sell-side Analyst Consensus Figures
25 april 2024, 14:30 cet arcelormittal (‘the company') today announces the publication of its first quarter 2024 sell-side analyst consensus figures. the consensus figures are based on analysts' estimates recorded on an external web-based tool provided and managed by an independent company, visible alpha.
2024-04-23 09:10:00 - Press Release
Arcelormittal S.a.: Arcelormittal Publishes Its 2023 Integrated Annual Review
23 april 2024, 15:00 cet today, arcelormittal (‘the company') published its 2023 integrated annual review (‘iar'), which can be accessed here annualreview2023.arcelormittal.com . the 2023 iar, ‘preparing for the future', is structured in nine main chapters: our business and material issues driving change in our safety performance responsible energy use and lower-carbon futures air, water, land, biodiversity and ecosystems delivering a circular economy through innovation value chains our stakeholders trust attracting, retaining and developing our people communities and just transition governance and risk management new disclosures include: an update on further work done to evaluate physical and transition climate-related risks and opportunities, aligned with current and upcoming regulation.
2024-04-12 08:07:00 - Press Release
Prilenia To Present Latest Research From Its Pridopidine Programs For Huntington Disease And Als At Aan 2024
Naarden, netherlands & waltham, mass.--(business wire)--prilenia therapeutics b.v., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, today announced the presentation of the latest research from the pridopidine huntington disease (hd) and amyotrophic lateral sclerosis (als) programs at the american academy of neurology (aan) annual congress, in denver, colorad.
Latest News
2024-05-06 07:31:40 - MarketBeat
3 Metal Stocks Setting Up for Double-Digit Growth
The U.S. economy is pivoting into a new path for the year. After briefly jumping into its first expansionary reading in more than a year and a half, the ISM manufacturing PMI index just fell back into contraction for April.
2024-05-03 14:16:05 - Zacks Investment Research
ArcelorMittal's (MT) Q1 Earnings and Revenues Beat Estimates
ArcelorMittal's (MT) first-quarter earnings and sales beat the respective estimates despite lower year-over-year steel shipments.
2024-05-02 10:36:39 - Zacks Investment Research
ArcelorMittal (MT) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for ArcelorMittal (MT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
2024-04-29 10:21:29 - Zacks Investment Research
Stay Ahead of the Game With ArcelorMittal (MT) Q1 Earnings: Wall Street's Insights on Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for ArcelorMittal (MT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
2024-04-19 11:19:39 - InvestorPlace
3 Steel Stocks to Sell Now on Rising Input Costs and Interest Rate Fears
Things seemed to be slowing down after interest rates were raised eleven times in the previous 18 months, but according to the most recent data, the inflation rate for the last 12 months as of March is 3.5%, which has many people searching for steel stocks to sell from their portfolio. The logic is straightforward.
2024-04-12 08:07:00 - Business Wire
Prilenia to Present Latest Research from its Pridopidine Programs for Huntington Disease and ALS at AAN 2024
NAARDEN, Netherlands & WALTHAM, Mass.--(BUSINESS WIRE)--Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, today announced the presentation of the latest research from the pridopidine Huntington disease (HD) and amyotrophic lateral sclerosis (ALS) programs at the American Academy of Neurology (AAN) Annual Congress, in Denver, Colorad.
2024-03-13 12:46:12 - Zacks Investment Research
ArcelorMittal (MT) Inks Agreement to Acquire Stake in Vallourec
ArcelorMittal (MT) to acquire a 28.4% stake in Vallourec. This will enhance downstream presence with a focus on Vallourec's expertise and low-carbon production centers.
2024-03-12 17:12:09 - Reuters
ArcelorMittal to buy about 28.4% stake in Vallourec
Steelmaker ArcelorMittal said on Tuesday it will acquire an about 28.4% stake in Vallourec for around 955 million euros ($1.04 billion).
2024-03-12 14:23:04 - Seeking Alpha
ArcelorMittal: An Even Better Entry Point In Cyclical Steel
ArcelorMittal is one of the most significant global players in the cyclical steel segment. I would characterize it, at the right price, as a must-own sort of investment. I consider the company to be cheap at this time, and view the company as a "BUY" with an attractive PT and upside. The company may need a few years to achieve its targets, but I have no doubt that this is what the company will manage.
2024-03-04 12:56:04 - Zacks Investment Research
ArcelorMittal (MT) and Petrobras Forge Low-Carbon Partnership
ArcelorMittal (MT) and Petrobras join forces to explore low-carbon solutions in Brazil, including a carbon capture hub.